MLP accumulation and remodelling in the infarcted rat heart

European Journal of Heart Failure

Volumn 8, Issue 4, 2006, Pages 343-346

  Wilding, James R ^a   Lygate, Craig A ^a   Davies, Kay E ^a   Neubauer, Stefan ^a   Clarke, Kieran ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cytoskeleton; Echocardiography; Muscle LIM protein (MLP); Myocardial infarction (MI)

Indexed keywords

BETA TUBULIN; BIOLOGICAL MARKER; CYTOSKELETON PROTEIN; DESMIN; DYSTROPHIN; MYOSIN HEAVY CHAIN BETA; UTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; HEART DISEASE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FOLDING; PROTEIN FUNCTION; RAT; RAT STRAIN; SHAM FEEDING; SYSTOLIC BLOOD PRESSURE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; WESTERN BLOTTING;

ANIMALS; MALE; MUSCLE PROTEINS; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR;

EID: 33744787648     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.10.006     Document Type: Article

References (20)

1. Hoshijima M., and Chien K.R. Mixed signals in heart failure: cancer rules. J Clin Invest 109 (2002) 849-855
2. Knoll R., Hoshijima M., Hoffman H.M., et al. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111 (2002) 943-955
3. Yoshida H., Takahashi M., Koshimizu M., et al. Decrease in sarcoglycans and dystrophin in failing heart following acute myocardial infarction. Cardiovasc Res 59 (2003) 419-427
4. Vatta M., Stetson S.J., Perez-Verdia A., et al. Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy. Lancet 359 (2002) 936-941
5. Neagoe C., Kulke M., del Monte F., et al. Titin isoform switch in ischemic human heart disease. Circulation 106 (2002) 1333-1341
6. Heling A., Zimmermann R., Kostin S., et al. Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res 86 (2000) 846-853
7. Di Somma S., Marotta M., Salvatore G., et al. Changes in myocardial cytoskeletal intermediate filaments and myocyte contractile dysfunction in dilated cardiomyopathy: an in vivo study in humans. Heart 84 (2000) 659-667
8. Zolk O., Caroni P., and Bohm M. Decreased expression of the cardiac LIM domain protein MLP in chronic human heart failure. Circulation 101 (2000) 2674-2677
9. Tsutsui H., Ishihara K., and Cooper G. Cytoskeletal role in the contractile dysfunction of hypertrophied myocardium. Science 260 (1993) 682-687
10. Ishibashi Y., Takahashi M., Isomatsu Y., et al. Role of microtubules versus myosin heavy chain isoforms in contractile dysfunction of hypertrophied murine cardiocytes. Am J Physiol Heart Circ Physiol 285 (2003) H1270-H1285
11. Lygate C.A., Hulbert K., Monfared M., Cole M.A., Clarke K., and Neubauer S. The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction. Cardiovasc Res 58 (2003) 632-637
12. Wilding J.R., Schneider J.E., Sang A.E., Davies K.E., Neubauer S., and Clarke K. Dystrophin-and MLP-deficient mouse hearts: marked differences in morphology and function, but similar accumulation of cytoskeletal proteins. FASEB J 19 (2005) 79-81
13. Ju H., Zhao S., Tappia P.S., Panagia V., and Dixon I.M. Expression of Gq alpha and PLC-beta in scar and border tissue in heart failure due to myocardial infarction. Circulation 97 (1998) 892-899
14. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 79 (1999) 215-262
15. Orenstein T.L., Parker T.G., Butany J.W., et al. Favorable left ventricular remodeling following large myocardial infarction by exercise training. Effect on ventricular morphology and gene expression. J Clin Invest 96 (1995) 858-866
16. Heineke J., Ruetten H., Willenbockel C., et al. Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc. Proc Natl Acad Sci U S A (2005)
17. Heineke J., Kempf T., Kraft T., et al. Downregulation of cytoskeletal muscle LIM protein by nitric oxide: impact on cardiac myocyte hypertrophy. Circulation 107 (2003) 1424-1432
18. Anversa P., Beghi C., Kikkawa Y., and Olivetti G. Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth. Circ Res 58 (1986) 26-37
19. Di Somma S., Di Benedetto M.P., Salvatore G., et al. Desmin-free cardiomyocytes and myocardial dysfunction in end stage heart failure. Eur J Heart Fail 6 (2004) 389-398
20. Collins J.F., Pawloski-Dahm C., Davis M.G., Ball N., Dorn G.W., and Walsh II R.A. The role of the cytoskeleton in left ventricular pressure overload hypertrophy and failure. J Mol Cell Cardiol 28 (1996) 1435-1443